Sensus Healthcare, Inc. (NASDAQ:SRTS) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET
Company Participants
Kim Golodetz - LHA, IR
Joseph Sardano - Chairman and CEO
Michael Sardano - President and General Counsel
Javier Rampolla - CFO
Conference Call Participants
Jason Wittes - ROTH
Anthony Vendetti - Maxim Group
Eduardo Martinez-Montes - H.C. Wainwright & Co.
Operator
Good day and welcome to the Sensus Healthcare Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Kim Golodetz for opening remarks. Please go ahead.
Kim Golodetz
Kim Golodetz
Thank you. This is Kim Golodetz with LHA. Thank you all for participating in today's call.
Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel and Javier Rampolla, Chief Financial Officer.
As a reminder, some of the matters that will be discussed during today's call contain forward-looking statements within the meaning of federal securities laws. All statements other than historical facts that address at, Sensus Healthcare assumes, plans, expects, believes, intends or anticipates and other similar expressions will, should or may occur in the future, are forward-looking statements. The forward-looking statements are management's beliefs based on currently available information as of the date of this conference call, August 8, 2024.
Sensus Healthcare undertakes no obligation to revise or update any forward-looking statements, except as required by law. All forward-looking statements are subject to risks and uncertainties as described in the company's Forms 10-K and 10-Q.
During today's call, references will be made to certain non-GAAP financial measures. Sensus believes these measures provide useful information for investors yet they should not be considered as a substitute for GAAP nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in today's financial results press release. With that said, I'd like to turn the call over to Joe Sardano. Joe?
Joseph Sardano
Thank you, Kim and good afternoon, everyone. Our sales momentum continued in the second quarter of 2024 with very strong year-over-year revenue growth, along with positive net income and positive adjusted EBITDA. We continue to drive sales as our customers appear to have adjusted to the current macroeconomic environment. We shipped 23 systems during the quarter with three going international markets. This compares with 13 systems shipped in the year ago for the quarter. We were pleased that many of the shipments were for our SRT Vision systems with image-guided SRT with a higher number of such systems sold to a very large customer. We appreciate the dedication of this customer in choosing a far more patient-friendly and equally efficacious option versus most surgeries.